Clinical Neuropathology Practice Guide 3-2013: Levels of Evidence and Clinical Utility of Prognostic and Predictive Candidate Brain Tumor Biomarkers

Clinical Neuropathology - Germany
doi 10.5414/np300646
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Dustri-Verlgag Dr. Karl Feistle

Related search

Clinical Implications of Molecular Neuropathology and Biomarkers for Malignant Glioma

Current Neurology and Neuroscience Reports
NeuroscienceNeurology
2012English

Clinical Neuropathology Practice Guide 6-2013: Morphology and an Appropriate Immunohistochemical Screening Panel Aid in the Identification of Synovial Sarcoma by Neuropathologists

Clinical Neuropathology
MedicineForensic MedicinePathologyNeurology
2013English

Candidate Biomarkers for Cervical Cancer Treatment: Potential for Clinical Practice (Review)

Molecular and Clinical Oncology
Cancer ResearchOncology
2014English

Galectin-3: Clinical Utility and Prognostic Value in Patients With Heart Failure

Research Reports in Clinical Cardiology
2013English

Clinical Utility Gene Card For: 3-M Syndrome - Update 2013

European Journal of Human Genetics
Genetics
2013English

Clinical Neuropathology Practice Guide 06-2012: MGMT Testing in Elderly Glioblastoma Patients – Yes, but How?

Clinical Neuropathology
MedicineForensic MedicinePathologyNeurology
2012English

Clinical Trial Designs Incorporating Predictive Biomarkers

Cancer Treatment Reviews
MedicineOncologyRadiologyNuclear MedicineImaging
2016English

Diagnostic, Prognostic, and Predictive Molecular Biomarkers and the Utility of Molecular Imaging in Common Gastrointestinal Tumors

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2015English

Atlas of Clinical Neuropathology

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
1990English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy